With the shift to value-based care, healthcare providers are increasingly focused on balancing the need to provide the highest quality care with managing their operational costs. Through innovative care and pathway management there are growing opportunities to build scalable and sustainable cardiovascular healthcare models to drive improved treatment and outcomes, simplify data and insight gathering, remove excess costs from the system, and improve the care experience for patients. Philips has developed an integrated portfolio of products and solutions, combined with consultancy and services, which is enabling healthcare providers to improve diagnosis and care for cardiovascular patients, helping to optimize the length of their stay in hospital.
At ESC 2018 Philips is introducing its Interventional Hemodynamic system, which includes a patient monitoring device mounted at the table-side and a workstation in the control room with a user interface designed to simplify hemodynamic monitoring and assessment. The users in the control room can also perform hemodynamic analyses and display them in the exam room. Displaying all relevant physiologic waveforms and analyses at the table-side supports the clinician in making a real-time assessment of the patient’s condition during an intervention.
Also on show is Philips’ next-generation cardiovascular image and information management system, IntelliSpace Cardiovascular 3.1. Designed to help streamline workflow and improve operational performance throughout the cardiovascular service line, the latest version features enhanced security and enterprise protocols, seamless access to Philips’ QLAB and TOMTEC software tools, and the addition of browser-based reporting of stress echo tests.
Philips will also showcase Refinity ST, the next-generation rotational intravascular ultrasound (IVUS) catheter which provides detailed and accurate measurements of the vessel. With exceptional deliverability, 5F guide compatibility, and a 45 MHz high-resolution image, Refinity ST is designed to help clinicians meet the needs of their most complex percutaneous coronary interventional cases.
The 2018 European Society of Cardiology Congress 2018 will take place at the Messe in Munich, Germany. Visit Philips at Stand #H200, Hall A3. During the event, Philips will host a Satellite Symposium on Ultrasound featuring leading worldwide experts. For more information about the Philips symposium and other events, as well as general information about Philips’ presence at the show, visit www.philips.com/esc and follow @PhilipsLiveFrom for live #ESCCongress updates.
[1] EPIQ CVx and EPIQ CVxi are CE marked and have received 510(k) clearance from the U.S. Food and Drug Administration (FDA).
[2] EPD’s cardiac imaging and navigation system is not available for sale in the US.